The WHO Regional Office for Africa (AFRO) is recruiting (28 May 2024)

The WHO Regional Office for Africa (AFRO) is recruiting (28 May 2024)
The WHO Regional Office for Africa (AFRO) is recruiting (28 May 2024)
  1. Origins

Countries in the region African are faced with a health situation characterized by a constant threat of epidemics (meningitis, measles, malaria, etc.) and other communicable and non-communicable diseases. To meet these challenges, countries have adopted strategies including widespread vaccination, the most saving health policy.

At the WHO Regional Office for Africa (AFRO), the Vaccine Preventable Diseases (VPD) programme, located within the Universal Health Coverage/Communicable and Noncommunicable Diseases cluster, is working, in line with the business case of WHO immunization activities on the African continent. continent 2018-2030, to achieve, by 2030, sustainable control of VPDs; a significant reduction in mortality from measles, rubella, rotavirus and pneumococcal diseases; 1.9 million lives saved; 167 million cases of PVD avoided; $58 billion saved; and an estimated return on investment of 37 times.

Vaccine safety is essential to implementing and maintaining effective immunization programs. The rollout of Covid-19 vaccines has highlighted the safety concerns of vaccination recipients, underscoring the need for adequate monitoring and response to adverse events. WHO-AFRO provides technical support to countries to strengthen their vaccine safety systems and effective safety monitoring during immunization activities.

With the upcoming introduction of new vaccines and special vaccination activities, the UCN-VPD is building a roster of consultants who can be deployed to support effective vaccine safety monitoring. The existence of this file should reduce deployment times, particularly in the event of an emergency. The objective of the deployment is to facilitate safety monitoring of vaccine use in the African Region by providing technical support in:

  • building capacity of health workers in vaccine safety monitoring
  • comprehensive data collection when investigating serious cases of AEFI following vaccination
  • compilation of MAPI data at all levels and its timely transmission via the national MAPI feed for use
  • the investigation of serious cases
  • the collaboration of national actors in terms of pharmacovigilance
  • pharmacovigilance supervision, integrated or targeted
  • the establishment of active research protocols
  • organize and report on meetings of the national AEFI committee
  • execution of the risk communication strategy
  • Document successes

2) Deliverables:

All AEFI reports shared timely in Vigibase

At least 60% of serious AEFIs were investigated within 1 week of onset and 90% within 3 weeks.

Pharmacovigilance data in national weeklies SIMR

Monthly monitoring reports

Reports of all expert committee meetings

All causally assessed cases calculated in the Causality Assessment archive form and updated in Vigiflow

Documented success stories

Tracking Monthly Milestones

3) Qualifications, experience, skills and languages

Education (qualifications)


  • Master’s degree in public health or epidemiology or a related field from a recognized institution.


  • Doctorate or PhD in medicine or pharmacy or public health.


Essential :

  • Minimum of 7 years in a health program, research institution or medical/pharmaceutical practice.
  • Experience in implementing a national disease surveillance or pharmacovigilance system
  • Experience working in Africa or developing countries.


  • Experience working with national stakeholders on pharmacovigilance including national regulatory authority, Expanded Program on Immunization, Disease Surveillance and Control.
  • Demonstrated understanding of the hospital environment for the management of serious cases
  • Demonstrated ability to organize expert committee meetings.
  • Experience with WHO or other UN system agencies or international NGOs


  • Proven skills in communicating results
  • Capacity building skills, including development of training materials
  • Ability to work with a wide range of stakeholders

4) Languages ​​and level required


  • Extensive knowledge of English, French or Portuguese


  • Intermediate knowledge of other UN languages.

5) Location

Multiple, in the WHO African Region;

6) Remuneration

Band Tier B: $8,500 – $9,980 per month

7) Expected duration of the contract

3 months or more, depending on needs.

Click here to apply

Find opportunities on our TikTok account.



NEXT Even at 60, go out covered: sexually transmitted diseases are on the rise among “straight people of a certain age”